Chemotherapy source book / editors, Michael C. Perry, associate editors, Donald C. Doll, Carl E. Freter.

Perry's The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practi...

Full description

Saved in:
Bibliographic Details
Other Authors: Perry, Michael C. (Michael Clinton), 1945-, Doll, Donald C., Freter, Carl E.
Format: eBook
Language:English
Published: Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, ©2012.
Edition:5th ed.
Subjects:
Online Access:Click for online access

MARC

LEADER 00000cam a2200000 a 4500
001 ocn810314020
003 OCoLC
005 20240623213015.0
006 m o d
007 cr cn|||||||||
008 120111s2012 paua ob 001 0 eng d
040 |a LGG  |b eng  |e pn  |c LGG  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCF  |d YDXCP  |d TVJ  |d OCLCO  |d CUX  |d EBLCP  |d OCLCQ  |d BIBBD  |d OCLCQ  |d MERUC  |d USU  |d LOA  |d OCLCQ  |d COCUF  |d OCLCO  |d K6U  |d STF  |d PIFAG  |d FVL  |d ZCU  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d ICG  |d VT2  |d OCLCQ  |d WYU  |d OCLCA  |d TKN  |d AU@  |d UKMGB  |d DKC  |d OCLCO  |d OCLCQ  |d UX1  |d OCLCQ  |d OCLCA  |d UKAHL  |d OCLCQ  |d NLW  |d CASUM  |d OCLCA  |d UCW  |d EUN  |d UIU  |d OCLCO  |d CANEL  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL  |d OCLCQ  |d UEJ  |d OCLCO 
015 |a GBB6F5966  |2 bnb 
016 7 |a 000048454639  |2 AU 
016 7 |a 017819484  |2 Uk 
019 |a 873761655  |a 908075556  |a 923526004  |a 972505647  |a 1007082965  |a 1055372345  |a 1058073049  |a 1058518218  |a 1059118878  |a 1062346636  |a 1066430044  |a 1081249249  |a 1091202487  |a 1097160959  |a 1110443318  |a 1119964216  |a 1141486104  |a 1154942722  |a 1196348459  |a 1224606249  |a 1228613672  |a 1282934423  |a 1296411924 
020 |a 9781469874685  |q (electronic bk.) 
020 |a 1469874687  |q (electronic bk.) 
020 |a 9781469803432  |q (EPUB) 
020 |a 1469803437  |q (EPUB) 
020 |z 9781451101454  |q (alk. paper) 
020 |z 1451101457  |q (alk. paper) 
024 8 |a 40021000554 
035 |a (OCoLC)810314020  |z (OCoLC)873761655  |z (OCoLC)908075556  |z (OCoLC)923526004  |z (OCoLC)972505647  |z (OCoLC)1007082965  |z (OCoLC)1055372345  |z (OCoLC)1058073049  |z (OCoLC)1058518218  |z (OCoLC)1059118878  |z (OCoLC)1062346636  |z (OCoLC)1066430044  |z (OCoLC)1081249249  |z (OCoLC)1091202487  |z (OCoLC)1097160959  |z (OCoLC)1110443318  |z (OCoLC)1119964216  |z (OCoLC)1141486104  |z (OCoLC)1154942722  |z (OCoLC)1196348459  |z (OCoLC)1224606249  |z (OCoLC)1228613672  |z (OCoLC)1282934423  |z (OCoLC)1296411924 
037 |a 9781469803432  |b Ingram Content Group 
050 4 |a RC271.C5  |b C446 2012 
049 |a HCDD 
245 0 0 |a Chemotherapy source book /  |c editors, Michael C. Perry, associate editors, Donald C. Doll, Carl E. Freter. 
246 3 |a Perry's the chemotherapy source book 
250 |a 5th ed. 
260 |a Philadelphia :  |b Wolters Kluwer Health/Lippincott Williams & Wilkins,  |c ©2012. 
300 |a 1 online resource (xiv, 833 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
504 |a Includes bibliographical references and index. 
505 0 |a Scientific basis of cancer chemotherapy -- Norton-Simon hypothesis -- Drug resistance -- Principles of chemotherapy -- Clinical trials -- Hematopoietic growth factors -- Biologic response modifiers: principles of biotherapy -- Intraventricular and intrathecal therapy -- Intraperitoneal chemotherapy -- Intraarterial chemotherapy -- Hematopoietic stem cell transplantation -- Oral toxicity -- Dermatologic toxicity -- Extravasation -- Hypersensitivity reactions -- Ocular side effects of cancer therapeutics -- Cardiotoxicity of cancer therapy -- Pulmonary toxicity of chemotherapeutic agents -- Gastrointestinal complications of chemotherapy -- Hepatotoxicity of chemotherapeutic agents -- Chemotherapy-induced renal and electrolyte dysfunction -- Chemotherapy-induced peripheral neuropathy -- Vascular toxicity of antineoplastic agents -- Second malignancies after chemotherapy -- Chemotherapy in pregnancy -- Gonadal complications and teratogenicity of cancer therapy -- Central venous access for chemotherapy -- Systemic therapy for advanced melanoma -- Chemotherapy of primary brain tumors -- Chemotherapy for head and neck cancer -- Chemotherapy of lung cancer -- Breast cancer -- Gastrointestional cancer -- Endocrine tumors -- Chemotherapy of genitourinary cancer -- Chemotherapy of gynecologic cancers -- Chemotherapy of carcinoma of unknown primary site -- Chemotherapy of bone and soft tissue sarcomas -- Chemotherapy for pediatric solid tumors -- Chemotherapy for childhood leukemia -- Chemotherapy of Hodgkin lymphoma -- Non-Hodgkin lymphoma -- Chronic lymphocytic leukemia -- Acute myeloid leukemia -- Myelodysplastic syndromes -- Management of myeloproliferative disorders and chronic myeloid leukemia -- Chemotherapy of multiple myeloma -- Appendics: I: Chemotherapeutic agents -- II: Chemotherapy programs -- III: Common terminology criteria for adverse events (CTCAE) version 4.0. 
520 |a Perry's The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practice of chemotherapy, and is meant to serve as a \u201cone-stop shop\u201d for information on choice of chemotherapeutic agents, treatment outlines, grading of side effects, and dose modification. 
506 1 |a Legal Deposit;  |c Only available on premises controlled by the deposit library and to one user at any one time;  |e The Legal Deposit Libraries (Non-Print Works) Regulations (UK).  |5 WlAbNL 
540 |a Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.  |5 WlAbNL 
650 0 |a Cancer  |x Chemotherapy. 
650 0 |a Antineoplastic agents. 
650 0 |a Antimitotic agents. 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Antimitotic agents  |2 fast 
650 7 |a Antineoplastic agents  |2 fast 
650 7 |a Cancer  |x Chemotherapy  |2 fast 
700 1 |a Perry, Michael C.  |q (Michael Clinton),  |d 1945-  |1 https://id.oclc.org/worldcat/entity/E39PCjJTgQHpcxVWKmQGk8ygTd 
700 1 |a Doll, Donald C. 
700 1 |a Freter, Carl E. 
758 |i has work:  |a The chemotherapy source book (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGbpTkvTPwVhYfvHWX9Kq3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |t Chemotherapy source book.  |b 5th ed.  |d Philadelphia : Wolters Kluwer/Lippincott Williams & Wilkins, ©2012  |z 9781451101454  |w (DLC) 2012001228  |w (OCoLC)756592107 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3418282  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD